SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-12-002787
Filing Date
2012-01-17
Accepted
2012-01-17 19:58:03
Documents
1
Period of Report
2011-12-20

Document Format Files

Seq Description Document Type Size
1 BIGGAR 122011 FORM 4/A rrd329599.html 4/A  
1 BIGGAR 122011 FORM 4/A rrd329599.xml 4/A 4049
  Complete submission text file 0001181431-12-002787.txt   5527
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Issuer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 667 MADISON AVE 17TH FLOOR NEW YORK NY 10021
Business Address
Biggar Stephen R (Reporting) CIK: 0001340380 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-23155 | Film No.: 12530735